Pityriasis Rosea and Immunosuppressive Drugs [Response to Letter]

Hao WuDepartment of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of China

https://orcid.org/0009-0003-6230-662X

Qing-Jie JiDepartment of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of China

Yu-Yang XuDepartment of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of China

Jian-Wei ZhuDepartment of Dermatology, Quzhou TCM Hospital at the Junction of Four Provinces Affiliated to Zhejiang Chinese Medical University, Quzhou, People’s Republic of ChinaCorrespondence[email protected]

References

Yoon JH, Park EJ, Park HR, Kim KJ, Kim KH. Histological and immunohistopathological differentiation between guttate psoriasis and pityriasis rosea. Australas J Dermatol. 2020;61(4):e481–e484. doi:10.1111/ajd.13370
PubMed Web of Science ®Google Scholar
Eslick GD. Atypical pityriasis rosea or psoriasis guttata? Early examination is the key to a correct diagnosis. Int J Dermatol. 2002;41(11):788–791. doi:10.1046/j.1365-4362.2002.01627.x
PubMed Web of Science ®Google Scholar
Drago F, Broccolo F, Ciccarese G, Rebora A, Parodi A. Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. Dermatology. 2015;230(1):23–26. doi:10.1159/000368352
PubMed Web of Science ®Google Scholar
Simpson EL, Sinclair R, Forman S, et al. Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, Phase 3 trial. Lancet. 2020;396(10246):255–266. doi:10.1016/S0140-6736(20)30732-7
PubMed Web of Science ®Google Scholar

Pityriasis Rosea and Immunosuppressive Drugs [Response to Letter]

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Pityriasis Rosea and Immunosuppressive Drugs [Response to Letter]

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date